Format

Send to

Choose Destination
JAMA Pediatr. 2019 Mar 11. doi: 10.1001/jamapediatrics.2019.0101. [Epub ahead of print]

Cost Implications of Escalating Intravenous Acetaminophen Use in Children.

Author information

1
Pediatric Therapeutics and Regulatory Science Initiative, Computational Health Informatics Program (CHIP), Boston Children's Hospital, Boston, Massachusetts.
2
Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
3
Center for Applied Pediatric Quality Analytics, Boston Children's Hospital, Boston, Massachusetts.
4
Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
5
Department of Anesthesiology, Critical Care, and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts.
6
Department of Anaesthesiology, Harvard Medical School, Boston, Massachusetts.
PMID:
30855654
PMCID:
PMC6503505
[Available on 2020-03-11]
DOI:
10.1001/jamapediatrics.2019.0101

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center